1. Smith LA. Diagnostic Parasitology. In: Mahon CR, Lehman DC, Manuselis G (ed). Textbook of Diagnostic Microbiology. 5th edition. Saunders Elsevier, 2015.
2. Spickler, Anna Rovid. “Title of Factsheet.” “Date of Factsheet (Last Updated).” At cfsph.iastate.edu/diseaseinfo/factsheets/ https://www.cfsph.iastate.edu/Factsheets/pdfs/larva_migrans.pdf
Erişim tarihi: 07.07.2024
3. De Paiva Macedo J, Alvarenga IM, De Castro PH, et al. Larva Migrans: a growing public health problem highlighted by a beach tennis outbreak. Int J Sci Manage Tourism. 2023; 9: 569–83.
4. Jayaram Paniker CK, Ghosh S. Paniker’s Textbook of Medical Parasitology. Seventh edition; 2013.
5. Osman S, Tarnari N, Ahsan A, Ahmed KAHM. Cutaneous Larva Migrans (CLM) may not be easy to diagnose: a case report and narrative review. Oxf Med Case Reports. 2024; 25: omae025.
6. Shrestha A, KC K, Baral A, Shrestha R, Shrestha R. Cutaneous larva migrans in a child: a case report and review of literature. Ann Med Surg. 2023; 86(1): 530-534.
7. Wesołowski R, Mila-Kierzenkowska C, Pawłowska M, Szewczyk-Golec K, Kałużna L, Wozniak AM. Cutaneous larva migrans imported from a tropical trip – Case report and literature review.
Ann Agric Environ Med. 2021; 28(4): 709-712.
8. Centers for Disease Control and Prevention (CDC). Hookworm (Extraintestinal) . Erişim linki: https://www.cdc.gov/dpdx/zoonotichookworm/index.html (Erişim tarihi: 28.07.2024)
9. Centers for Disease Control and Prevention (CDC). About Zoonotic Hookworm. Erişim linki: https://www.cdc.gov/zoonotic-hookworm/about/index.html?CDC_AAref_Val=https://www.
cdc.gov/parasites/zoonotichookworm/health_professionals/index.%2520html (Erişim tarihi: 28.07.2024)
10. Leung AKC, Barankin B, Hon KLE. Cutaneous Larva Migrans. Recent Pat Inflamm Allergy Drug Discov. 2017; 11(1): 2-11.
11. Nash TE. Visceral Larva Migrans and Others Uncommon Helminth Infections. In:. Bennett JE, Dolin R, Blaser MJ eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious
Diseases. Eighth Edition. Philadelphia, Elsevier saunders; 2015.
12. Ramondetta A, Ribero S, Quaglino P, Broganelli P. In vivo observation of cutaneous larva migrans by fluorescence-advanced videodermatoscopy. Emerg Infect Dis. 2021; 27: 281–3.
13. http://www.antimicrobe.org/b08.asp (Erişim tarihi: 07.07.2024)
14. Kuna A, Olszański R, Sikorska K. Cutaneous Larva Migrans as a frequent problem in travellers. Int Marit Health. 2023; 74(4): 259-264.
15. Bouchaud O, Houze S, Schiemann R, et al. Cutaneous larva migrans in travelers: A prospective study, with assessment of therapy with ivermectin. Clin Infect Dis. 2000; 31: 493-8.
16. World Health Organization (WHO). Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24
months. Erişim linki: https://www.who.int/publications/i/item/WHO-CDS-CPE-PVC-2002.4 (Erişim tarihi:28.07.2024)
17. Tan ST, Firmansyah Y, Hendsun H. Permethrin potential as an alternative therapy for the eradication of cutaneous Larva Migrans (CLM)—case report. J Kesehatan. 2023; 11: 56–61.
18. Chen J, Liu Q, Liu GH, et al. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty. 2018; 7(1): 59.
19. Selek M, Karagöz E, Baylan O. Toxocariasis: a review. Medicine Science. 2016; 5(4): 1063 – 1067.
20. Suhad YJ, Afkar MH. A review study for Toxocariasis. GSC Biological and Pharmaceutical Sciences. 2021; 16(03): 191–199.
21. Joy AT, Chris OI, Godwin NC. Toxocariasis and Public Health: An Epidemiological Review. Glob J Infect Dis Clin Res. 2017; 3(1): 028-039.
22. Centers for Disease Control and Prevention (CDC). Toxocariasis. Erişim linki: https://www.cdc.gov/dpdx/toxocariasis/index.html (Erişim tarihi: 28.07.2024)
23. Magnaval JF, Bouhsira E, Fillaux J. Therapy and Prevention for Human Toxocariasis. Microorganisms. 2022; 10: 241.